http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20070022855-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-243 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4412 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-132 |
filingDate | 2005-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2007-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20070022855-A |
titleOfInvention | Anti-tumor effect enhancers, anti-tumor agents and cancer treatment methods |
abstract | A therapeutically effective amount of tegapur, containing an effective amount of cis-oxalate (1R, 2R-diaminocyclohexane) platinum (II) as an active ingredient, an effective amount of anti-tumor effect-enhancing gimeracil, and an effective amount of odor for suppressing side effects Antitumor effect enhancers that enhance the antitumor activity of antitumor agents containing terasil potassium; A method for treating cancer, comprising administering to the mammal an effective amount of cis-oxalate (1R, 2R-diaminocyclohexane) platinum (II) in order to enhance the antitumor agent and antitumor effect. Two or more separate components each comprising, alone or in any combination, an active ingredient consisting of tegapur, gimeracil, potassium terrasil, and cis-oxalate (1R, 2R-diaminocyclohexane) platinum (II) An anti-tumor agent and kit in the form of a formulation consisting of a formulation or in the form of a formulation comprising all active ingredients.n n n Tegapur, gimeracil, oterasyl potassium, antitumor effect enhancer, cis-oxalate platinum, cancer treatment method, antitumor agent, kit |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101309440-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20110135980-A |
priorityDate | 2004-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 58.